Polyurethane elastomer for heart assist devices

Claim 2

A bladder for devices intended for implantation in a human said bladder being characterized in that it is formed from an aliphatic polyurethane elastomer said polyurethane elastomer being the reaction product of: (1) dicyclohexyl methane diisocyanate; (2) poly tetra methylene ether glycol having a molecular weight between the range of 500-5,000; (3) a low molecular weight glycol selected from the group consisting of propylene glycol, dipropylene glycol ethylene glycol, diethylene glycol, neopentyl glycol and cyclohexane dimethanol, and (4) a trihydric alcohol crosslinker, said trihydric alcohol being selected from the group consisting of glycerol, pentaerythritol, trimethylolethane, trimethylolpropane, and mannitol said polyurethane elastomer having a molecular weight within the range of 80-120 thousand molecular weight units.

Claim 3

The bladder as set forth in claim 1 wherein said low molecular weight glycol is cyclohexane dimethanol.

Claim 4

The bladder as set forth in claim 1 wherein the molecular weight of the poly tetra methylene ether glycol is between the range of 1,000 to 3,000 molecular weight units.

Claim 5

The bladder as set forth in claim 2 wherein the molecular weight of the poly tetra methylene ether glycol is between the range of 1,000 to 3,000 molecular weight units.

Claim 6

The bladder as set forth in claim 1 wherein said trihydric alcohol is trimethylolpropane.

Claim 7

The bladder as set forth in claim 2 wherein said trihydric alcohol is trimethyolpropane.

Claim 8

The bladder as set forth in claim 3 wherein said trihydric alcohol is trimethylolpropane.

Claim 9

The bladder as set forth in claim 4 wherein said trihydric alcohol is trimethylolpropane.

Claim 10

A polyurethane elastomer, said polyurethane elastomer being the reaction product of: (1) an aliphatic diisocyanate selected from the group consisting of hexamethylene diisocyanate, isophorone diisocyanate, trimethyl hexamethylene diisocyanate, dicyclohexyl methane diisocyanate, and dimer acid diisocyanate; p1 (2) cyclohexane dimethanol; and (3) a poly tetra methylene ether polyol having a molecular weight in the range of 500-5000 molecular weight units, the resulting polymer having a molecular weight between the range of 80-120 thousand molecular units.

Claim 11

A polyurethane elastomer, said polyurethane elastomer being the reaction product of: (1) an aliphatic diisocyanate selected from the group consisting of hexamethylene diisocyanate, isophorone diisocyanate, trimethyl hexamethylene diisocyanate, dicyclohexyl methane diisocyanate, and dimer acid diisocyanate; p1 (2) cyclohexane dimethanol; and (3) a poly tetra methylene ether polyol having a molecular weight in the range of 500-5000 molecular weight units, the resulting polymer having a molecular weight between the range of 80-120 thousand molecular units.

Claim 12

The polyurethane elastomer as set forth in claim 9 wherein said aliphatic diisocyanate is dicyclohexyl methane diisocyanate.

Claim 13

The polyurethane elastomer as set forth in claim 10 wherein the molecular weight of said poly tetra methylene ether polyol is between the range of 1000-3000.

Claim 14

A polyurethane elastomer, said polyurethane elastomer being the reaction product of: (1) an aliphatic diisocyanate selected from the group consisting of hexamethylene diisocyanate, isophorone diisocyanate, trimethyl hexamethylene diisocyanate, dicyclohexyl methane diisocyanate, and dimer acid diisocyanate; (2) cyclohexane dimethanol; (3) a poly tetra methylene ether polyol having a molecular weight in the range of 500-5000 molecular weight units, and (4) a trihydric alcohol crosslinker, said trihydric alcohol being selected from the group consisting of glycerol, pentaerythritol, trimethylolethane, trimethylolethane, trimethylolpropane, and mannitol.

Claim 15

A polyurethane elastomer, said polyurethane elastomer being the reaction product of: (1) an aliphatic diisocyanate selected from the group consisting of hexamethylene diisocyanate, isophorone diisocyanate, trimethyl hexamethylene diisocyanate, dicyclohexyl methane diisocyanate, and dimer acid diisocyanate; (2) cyclohexane dimethanol; (3) a poly tetra methylene ether polyol having a molecular weight in the range of 500-5000 molecular weight units, and (4) a trihydric alcohol crosslinker, said trihydric alcohol being selected from the group consisting of glycerol, pentaerythritol, trimethylolethane, trimethylolethane, trimethylolpropane, and mannitol.

Claim 16

The polyurethane elastomer as set forth in claim 12 wherein said aliphatic diisocyanate is dicyclohexyl methane diisocyanate.

Claim 17

The polyurethane elastomer as set forth in claim 13 wherein the molecular weight of said poly tetra methylene ether polyol is between the range of 1000-3000.

Claim 18

The elastomer as set forth in claim 12 wherein the trihydric alcohol is trimethylolpropane.

Claim 19

The elastomer as set forth in claim 13 wherein the trihydric alcohol is trimethylolpropane.

Claim 20

The elastomer as set forth in claim 14 wherein the trihydric alcohol is trimethylolpropane.

Claim 21

A process for forming a bladder for use in devices intended for chronic human implantation comprising the following steps: A. providing reactants comprising 1. a diisocyanate selected from the group consisting of hexamethylene diisocyanate, trimethyl hexamethylene diisocyanate, dicyclohexyl methane diisocyanate and dimer acid diisocyanate; 2. poly tetra methylene ether glycol having a molecular weight within a range of 500-5000 molecular weight units, 3. a low molecular weight glycol selected from the group consisting of propylene glycol, dipropylene glycol, ethylene glycol, diethylene glycol, neopentyl glycol, and cyclohexane dimethanol, and 4. a trihydric alcohol crosslinker, said trihydric alcohol being selected from the group consisting of glycerol, pentaerythritol, trimethylolethane, trimethylolpropane, and mannitol; B. mixing the reactants to form a reactive mixture C. degassing the reactive mixture to remove entrained air D. forcing the reactive mixture into a mold having a configuration of a bladder E. curing the mixture in the mold to form a polyurethane elastomer, and F. removing the bladder from the mold.

Claim 22

A process for forming a bladder for use in devices intended for chronic human implantation comprising the following steps: A. providing reactants comprising 1. a diisocyanate selected from the group consisting of hexamethylene diisocyanate, trimethyl hexamethylene diisocyanate, dicyclohexyl methane diisocyanate and dimer acid diisocyanate; 2. poly tetra methylene ether glycol having a molecular weight within a range of 500-5000 molecular weight units, 3. a low molecular weight glycol selected from the group consisting of propylene glycol, dipropylene glycol, ethylene glycol, diethylene glycol, neopentyl glycol, and cyclohexane dimethanol, and 4. a trihydric alcohol crosslinker, said trihydric alcohol being selected from the group consisting of glycerol, pentaerythritol, trimethylolethane, trimethylolpropane, and mannitol; B. mixing the reactants to form a reactive mixture C. degassing the reactive mixture to remove entrained air D. forcing the reactive mixture into a mold having a configuration of a bladder E. curing the mixture in the mold to form a polyurethane elastomer, and F. removing the bladder from the mold.

Claim 23

The process as set forth in claim 18 wherein in step E the mixture is cured in the mold by being heated to at least 110° C. for at least four hours.

Claim 24

A polyurethane elastomer having the following formula ##STR7## where x, y and z are any positive integers between 1 and 4, the molecular weight of [(CH 2 CH 2 CH 2 CH 2 )n 1 ] is between the range of 500-5000 and the molecular weight of the elastomer is between the range of 80,000-120,000.

Claim 25

A polyurethane elastomer having the following formula ##STR7## where x, y and z are any positive integers between 1 and 4, the molecular weight of [(CH 2 CH 2 CH 2 CH 2 )n 1 ] is between the range of 500-5000 and the molecular weight of the elastomer is between the range of 80,000-120,000.

Claim 26

The process as set forth in claim 18 wherein in step A-3 the low molecular weight glycol that is provided is cyclohexane dimethanol.

Claim 27

The process as set forth in claim 21 wherein in step A-1 the diisocyanate provided is dicyclohexyl methane diisocyanate.